Dual Chamber Pre-Filled Syringes Market: Overview
The global Dual Chamber Pre-Filled Syringes market size was worth USD 150.26 million in 2022 and is estimated to grow to USD 260.11 million by 2030, with a CAGR of approximately 7.1 % Over the forecast from 2023 to 2030.
Dual Chamber syringes have a numeral of benefits over traditional drug delivery systems
Prefilled Dual Chamber Devices are combination devices that contain freeze-dried drugs and diluents in two different chambers. Dual Chamber syringes have a digit of benefits over traditional drug delivery systems, including accurate dosing, ease of handling, seal integrity, and high stability, and thus are good alternatives. Many processing and manufacturing challenges are managed in prefilled dual chamber devices, increasing in the market. Dual Chamber Devices such as Mix jet, Vetter Lyo-Ject, and LyoTwist are evolving prevalent choices for physicians and patients in need of immediate acting and safe delivery (i.e., no needle sticks injuries or airborne bacterial contaminants), especially enhancing patient compliance by simply applying pressure to the end plunger after mixing and dissolving freeze-dried powder.
The global dual chamber prefilled syringes market Driven by the increasing numeral of lyophilized drugs, the rate of chronic disease incidence is growing, there is a high demand for low-cost, non-reactive glass dual chamber prefilled syringes, and the development of the dual chamber prefilled syringes market is helped by improvements in the biopharmaceutical industry.
Growth of Successful Freeze-Dried Biopharmaceuticals
The multiple challenging and complex components of prefilled Dual Chamber Devices are manufactured, particularly in the expansion of viable freeze-dried biopharmaceuticals. Due to the configuration (i.e., long, slim, and restricted contact surface), freeze-drying DCDs is a complex process, and medium packing materials would differ immensely from those operated for vials. Various academics are presently working to create adequate solutions to challenges associated with the manufacturing of prefilled Dual Chamber Devices. Some of these concerns have been managed, such as the enhancement of an easy process for freeze-dried items using the tray-filling technique in the Dual Chamber Device. In a mixture with an aluminum block and a metal cartridge, the freeze-drying stage is finished with the needle down.
North America is calculated to account for the most increased share of the global Dual Chamber Pre-Filled Syringes Market.
North America is calculated to have the largest share in the global dual chamber prefilled syringes market. The growing aging population, powerful medical device manufacturing capacity, growing per capita healthcare spending, and raised health awareness in the country are propelling the market in the region.
Dual Chamber Pre-Filled Syringes Market: Competitive Landscape
Some of the major competitors dominating the global Dual Chamber Pre-Filled Syringes market include-
- AbbVie Inc.
- Amgen Inc.
- Arte Corp.
- AstraZeneca PLC
- Bespak Europe Ltd
- Catalent, Inc.
- Credence MedSystems
- Gerresheimer AG
- Nipro Corporation
- Novartis AG
- Otsuka America Pharmaceutical Inc.
- Owen Mumford Ltd
- Pfizer Inc.
- Schott AG
The Global Dual Chamber Pre-Filled Syringes Market is segmented as follows:
Dual Chamber Prefilled Syringes Market by Type Outlook (Revenue, USD Million, 2017 – 2030)
- Conventional Dual Chamber Prefilled Syringes
- Safety Dual Chamber Prefilled Syringes
Dual Chamber Prefilled Syringes Market by Application Outlook (Revenue, USD Million, 2017 – 2030)
- Other Application
Dual Chamber Prefilled Syringes Market by End-User Outlook (Revenue, USD Million, 2017 – 2030)
- Hospitals and Clinics
- Home Care Settings
- Research Laboratories
- Pharma & Biotech Companies
- Other End-User
Dual Chamber Prefilled Syringes Market by Material Outlook (Revenue, USD Million, 2017 – 2030)
- Stainless Steel
Dual Chamber Prefilled Syringes Market by Region Outlook (Revenue, USD Million, 2017 – 2030)
- North America
- The UK
- Rest of Europe
- Asia Pacific
- New Zealand
- South Korea
- Southeast Asia
- Rest of Southeast Asia
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Rest of Latin America
Scope of the Dual Chamber Pre-Filled Syringes Market Report
Market size available for years
Base year considered
Value (USD Million) and Volume (Thousand Units)
Type, Product, Indication Material, and Region
North America, Europe, Asia Pacific, LAMEA
AbbVie Inc; Amgen Inc; Arte Corp; AstraZeneca PLC; Bespak Europe Ltd; Catalent, Inc; Credence MedSystems; Gerresheimer AG; Nipro Corporation; Novartis AG; Otsuka America Pharmaceutical Inc; Owen Mumford Ltd; Pfizer Inc; Schott AG